Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.153
H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Jan. 4, 2021
- Latest Major Action March 4, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
18 (17 Democrats, 1 Republican)
Bill Version
- Introduced in House - Jan. 4, 2021
Bill Summary
Protecting Consumer Access to Generic Drugs Act of 2021 This bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Specifically, such an agreement shall, with some exceptions, be a violation of the bill if the filer of a subsequent application to market a drug or biological...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| March 4, 2021 |
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
|
| Feb. 2, 2021 |
Referred to the Subcommittee on Health.
|
| Jan. 4, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Jan. 4, 2021 |
Introduced in the House by Bobby L. Rush (D-Ill.) |